BBSRC STFC Facility Access Funding for OET

BBSRC STFC Facility Access Funding for OET

Baculovirus expression vectors (BEVS) have become one of the most versatile and successful systems to produce recombinant protein subunit vaccines, for illnesses including influenza, Covid-19 and other animal diseases. An issue with producing a minority of recombinant baculoviruses in insect cells at scale is low yields and instability, which is thought to be linked to the structural […]

Vaccine technology IX Conference

After a very successful conference to the ECV 2023 in Gdansk we are now looking forward to attending more conferences and letting the scientific community know about the hard work we do here at Oxford expression technologies ltd. We already have another trip booked in, where will be attending and sponsoring the Vaccine technology IX […]

8th European Congress of Virology 2023

OET is excited to announce that we will be attending the 8th Eurpoean Congress of Virology in Gdansk on the 4th May 2023 for the 8th Eurpoean Congress of Virology. We will have an exciting opportunity to present our recent work on developing a vaccine for the CCHF virus with a talk from Mine Aksular […]

Postdoctoral Research Assistant in Molecular Biology

OET is working in collaboration with Oxford Brookes Insect Virus Research Group on a an exciting new project; NanoZoo. This project aims to use the baculovirus expression system to produce surface antigens of viral pathogens of farm animals (chickens and pigs) to develop novel vaccines. To find out more information and apply please follow this link; […]

OET Published in MediaPlanet’s Value of Vaccines Campaign Magazine

We’re proud to have been involved in Media Planet’s  Value of Vaccines campaign and contributing to an outstanding edition of their magazine. We talk more about our current research & development project, working on making a vaccine for the Crimean Congo Haemorrhagic Fever (CCHF). Read our article here or browse the full edition below! #ValueofVaccines

OET awarded a share of £10m for vaccine research to combat epidemics in developing countries

Oxford Expression Technologies Ltd (OET) is pleased to announce that it has been awarded £377K, one of 22 successful awards, as part of the ‘SBRI – Vaccines for epidemic diseases: Readiness for clinical development and regulatory submission’ programme. This research is funded by the Department of Health and Social Care as part of the UK […]

Latest Academic Paper from OET

Optimizing Recombinant Baculovirus Vector Design for Protein Production in Insect Cells

John Harris joins OET as Chair of the Board of Directors

Oxford Expression Technologies is delighted to welcome John Harris as Chair of the Board of Directors. John brings to OET extensive leadership, Board, and managerial competence developed within well respected Blue-Chip, Governmental and SME organisations specialised in the Life Sciences Sectors. Over his 37 years working in this space (including 23 years at CEO level), […]

OET in Top 5 Virology Solution Providers 2021

OET is delighted to be featured as one of the top 5 virology solution providers for 2021 in the annual Pharmatech Outlook Awards.  The full listing can be found here  An interview with Prof Linda King, founder and CEO of Oxford Expression Technologies can be found here.

flashBAC chosen to produce proteins for Dengue and Zika antibody tests

Oxford Expression Technologies is delighted that their flashBAC TM expression system was chosen as the tool to produce the glycoproteins for the development of a novel antigen lateral flow antibody test for dengue and Zika. Details of the project are described in this press release from Excivion Ltd.

Get in touch